Help progress science and biomedical research discoveries along the development pathway to patient benefit. Offer academics assistance with: defining development and regulatory strategy; building and managing links to available resources; funder liaising and reporting requirements; managing risks and issues, follow-on funding and on-going project management and support. Bridge the gap between academia and the commercial healthcare sector by de-risking UCLís novel science a team of 24 highly experienced industrial translational scientists tasked with establishing the organisational culture, capability and processes necessary to deliver the UCL and BRCís mission of "Accelerating translation for health and wealth". The TRO supports the development of early stage research from across UCL and its partner hospitals, into projects attractive for translational funding or further development with partners and nurture access to complementary capacity, expertise and skills in translational science. The TRO achieves this through the integrated activities of three specialist groups a Drug Discovery Group (DDG) provides expert advice and practical support for small molecule drug discovery projects across UCL; a Translational Research Group who provide experienced project leaders to guide projects (gene, cell and regenerative medicine therapies, devices, diagnostics, small molecules) through their development; and an Industrial Partnerships Group who initiate and manage relationships with industry. The team have a proven track record of therapeutic delivery and work in partnership with academics and industry partners, enhancing projects to optimise the chances of long-term success and benefit to patients.